2,181
Views
5
CrossRef citations to date
0
Altmetric
Original research

Phase II single-arm study of brentuximab vedotin in Chinese patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large cell lymphoma

, , , , , , , , , , , & show all
Pages 867-875 | Received 08 Apr 2021, Accepted 10 Jun 2021, Published online: 24 Aug 2021